The expiration of stock-sale lockups for Ampio Pharmaceuticals' (AMPE +7%) executives and insiders - due at the end of June and in mid-July - just happens to coincide with the stock's recent run up. The Street's Adam Feuerstein is calling shenanigans on the company, accusing the company of fueling a promotional blitz in an effort to pump up the price for the benefit of insiders.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs